Roche and Synta Pharmaceuticals entered an agreement potentially worth $1.025 billion to discover, develop, and commercialize small molecule anti-inflammatories. Roche will pay Synta $25 million upfront, which includes $9 million in research funding ...
Read more...
CHICAGO, Jan 7 (Reuters) - A drug used to suppress the immune system in cancer and rheumatoid arthritis has helped extend the life of a Minnesota boy struggling with a rare and deadly form of the genetic disorder Pompe disease. A team of researchers ...
Read more...
CHICAGO (Reuters) - A drug used to suppress the immune system in cancer and rheumatoid arthritis has helped extend the life of a Minnesota boy struggling with a rare and deadly form of the genetic disorder Pompe disease. A team of researchers led by ...
Read more...
Even arthritis doctors get arthritis. "I've had it for about five years," said Dr. James Louie, chief of rheumatology at Harbor-UCLA Medical Center. "I just take a little Motrin from time to time." Louie will speak about rheumatoid arthritis at a ...
Read more...
NEW YORK (AP) - Drugmaker Wyeth is in preliminary acquisition talks with Dutch vaccine maker Crucell NV, according to a statement from Crucell. The statement came shortly after a Wall Street Journal report saying Wyeth was in talks to buy Crucell ...
Read more...
FRIDAY, Jan. 4 (HealthDay News) -- Arthritic disease is the most common cause of disability in the United States and now affects 46 million Americans, or more than 21 percent of the adult population, a major new report finds. That number is expected ...
Read more...
The Sutter County Sheriff's Department is seeking the public's help in identifying human skeletal remains found Oct. 24 near the Feather River. According to the Chico State University Human Identification Laboratory, the bones are most likely those ...
Read more...